Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Recurrence × Indocyanine Green × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 12 Endometrial Neoplasms 6 Lymphatic Metastasis 4 Stomach Neoplasms 3 Melanoma 3 Uterine Cervical Neoplasms 2 Head and Neck Neoplasms 2 Colonic Neoplasms 2 Uterine Neoplasms 1 Solitary Pulmonary Nodule 1 Skull Base Neoplasms 1 Secondary Lymphedema 1 Recurrence 1 Rectal Neoplasms 1 Multiple Pulmonary Nodules 1 Mixed Tumor, Mesodermal 1 Lymphedema 1 Lung Neoplasms 1 Liver Neoplasms 1 Invasive Breast Cancer 1 Inflammatory Breast Neoplasms 1 Gastrointestinal Stromal Tumors 1 Gastrointestinal Diseases 1 Esophageal Neoplasms 1 Cervical Cancer Stage IB1 1 Carcinoma, Hepatocellular 1 Breast Cancer Lymphedema 1

Interventions

Radiotherapy 10 fludarabine phosphate 6 Cyclophosphamide 6 Peripheral Blood Stem Cell Transplantation 5 Filgrastim 5 Cyclosporine 5 Whole-Body Irradiation 4 Surgical Procedures, Operative 4 Radiofrequency Ablation 4 Mycophenolic Acid 4 Melphalan 4 Drug Therapy 4 Cisplatin 4 Busulfan 4 Antilymphocyte Serum 4 Surveys and Questionnaires 3 Radiosurgery 3 Methotrexate 3 Injections 3 Cord Blood Stem Cell Transplantation 3 fludarabine 2 Vinblastine 2 Videotape Recording 2 Standard of Care 2 Procarbazine 2 Prednisolone 2 Practice Guidelines as Topic 2 Mastectomy 2 Lidocaine 2 Hepatectomy 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02920216 2022-03-31

SALVADS-Fluo

Institut de Cancérologie de Lorraine

Phase NA Completed

Head and Neck Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡